Close

Roth Capital Upgrades Peregrine Pharmaceuticals (PPHM) to Buy

January 7, 2013 8:50 AM EST
Get Alerts PPHM Hot Sheet
Price: $0.61 --0%

Rating Summary:
    3 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 20 | Down: 14 | New: 22
Join SI Premium – FREE
Roth Capital upgraded Peregrine Pharmaceuticals (NASDAQ: PPHM) from Neutral to Buy with a price target of $2.70 (from $1.25).

For an analyst ratings summary and ratings history on Peregrine Pharmaceuticals click here. For more ratings news on Peregrine Pharmaceuticals click here.

Shares of Peregrine Pharmaceuticals closed at $1.35 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades

Related Entities

Roth Capital